Bioelectronics Profit Margin

The latest profit margin for BIEL is -193.46% as of March 2023. That compares with -12.3% in the prior-year period — down 1473.1% year over year. That is below the sector sector average of 13.23%. Investors often review this figure alongside Bioelectronics's historical trend and sector peers before judging valuation or financial health.

Over the past year, BIEL's profit margin moved from -12.3% to -193.46% — a 1473.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bioelectronics's valuation or profitability profile.

Against its sector companies, BIEL currently prints -193.46% for profit margin, while the sector average sits near 13.23%. That is roughly 1562.7% below the sector mean. Large gaps often invite a closer look at Bioelectronics's growth, margins, and balance sheet.

Profit Margin shows how effectively Bioelectronics converts resources into returns. At -193.46%, BIEL may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -12.3% in the prior-year period — down 1473.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BIEL's profit margin (-193.46%), review year-over-year change from -12.3%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.